PRESS RELEASE published on 10/20/2023 at 15:40, 2 years 3 months ago Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG
PRESS RELEASE published on 10/20/2023 at 15:18, 2 years 3 months ago EQS-Adhoc: Eckert & Ziegler Focuses on Core Competence and Prepares Split-Off of Clinical Assets
PRESS RELEASE published on 10/17/2023 at 16:57, 2 years 3 months ago EQS-Adhoc: Eckert & Ziegler Achieves Double-Digit Growth in Q3 versus Previous Year. Significant Jump in Sales also in First 9 Months, Earnings still Burdened by Special Items Compared to Same Period Last Year.
PRESS RELEASE published on 10/10/2023 at 15:00, 2 years 3 months ago Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225
PRESS RELEASE published on 09/28/2023 at 10:00, 2 years 4 months ago Eckert & Ziegler Receives Award for Professional Training
PRESS RELEASE published on 09/25/2023 at 23:17, 2 years 4 months ago EQS-Adhoc: Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma
PRESS RELEASE published on 09/13/2023 at 15:00, 2 years 4 months ago Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients
PRESS RELEASE published on 08/10/2023 at 07:45, 2 years 5 months ago Eckert & Ziegler Continues Positive Sales Development in the First Half of 2023
PRESS RELEASE published on 07/21/2023 at 15:21, 2 years 6 months ago EQS-Adhoc: Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.
PRESS RELEASE published on 06/08/2023 at 11:31, 2 years 7 months ago Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma
Published on 01/29/2026 at 18:45, 2 hours 26 minutes ago Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 3 hours 11 minutes ago PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/29/2026 at 17:00, 4 hours 11 minutes ago Sparta Reports on Delay in Filing Annual Financial Statements
Published on 01/29/2026 at 14:30, 6 hours 41 minutes ago Innodata Selected by Palantir to Accelerate Advanced Initiatives in AI-Powered Rodeo Modernization
Published on 01/29/2026 at 14:00, 7 hours 11 minutes ago Horizon Aircraft Partners with RAMPF to Manufacture the Fuselage for its Aircraft
Published on 01/29/2026 at 21:02, 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 20:59, 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 18:30, 2 hours 41 minutes ago ALPOU - Groupe POULAILLON chiffre d'affaires trimestriel T1 2025-2026 et Focus sur les activités
Published on 01/29/2026 at 18:00, 3 hours 11 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 18:00, 3 hours 11 minutes ago GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES CONSOLIDE ANNUEL 2025 : +2%
Published on 01/29/2026 at 17:45, 3 hours 26 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
